The Effect of Adjuvant Dexamethasone on Postoperative Pain, Analgesic Consumption and Block Properties in SFIB
1 other identifier
interventional
80
1 country
1
Brief Summary
The investigators aimed to demonstrate that dexamethasone added as an adjuvant to local anaesthetic agent in suprainguinal fascia iliaca block for effective postoperative analgesia after knee arthroplasty would prolong the duration of sensory block and reduce postoperative pain intensity and analgesic consumption.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 29, 2023
CompletedFirst Posted
Study publicly available on registry
August 7, 2023
CompletedStudy Start
First participant enrolled
August 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2024
CompletedApril 11, 2024
April 1, 2024
5 months
July 29, 2023
April 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative opioid consumption
First 24 hours total morphine consumption with patient controlled analgesia
Postoperative 24 hours
Secondary Outcomes (3)
Numerical Rating Scale
Postoperative 24 hours
Timed up and go test (TUG)
at 24th hour
Quadriceps muscle strength
at 24th hour
Study Arms (2)
Group SFIB (Suprainguinal fascia iliaca block)
ACTIVE COMPARATORIn the patient lying in the supine position, a high-frequency linear probe is inserted under sterile conditions, using an in-plane technique, 1 cm cephalad of the inguinal ligament with a needle. Using hydro-dissection, the fascia iliaca is separated from the iliac muscle and a space is created where the needle can be advanced cranially, and the procedure will be completed by injecting local anesthetic into this space.
Group SFIB+dexa (Suprainguinal fascia iliaca block+dexamethasone)
ACTIVE COMPARATORIn the patient lying in the supine position, a high-frequency linear probe is inserted under sterile conditions, using an in-plane technique, 1 cm cephalad of the inguinal ligament with a needle. Using hydro-dissection, the fascia iliaca is separated from the iliac muscle and a space is created where the needle can be advanced cranially, and the procedure will be completed by injecting local anesthetic+dexamethasone into this space.
Interventions
After the operation is completed, the fascia iliaca will be separated from the iliacus muscle. With ultrasound guidance, the local anesthetic injection will be made between the fascia and the muscle.
After the operation is completed, the fascia iliaca will be separated from the iliacus muscle. With ultrasound guidance, the local anesthetic+dexamethasone injection will be made between the fascia and the muscle.
Eligibility Criteria
You may qualify if:
- Having undergone unilateral knee replacement surgery under elective conditions,
- Age range of 18-75 years,
- American Society of Anesthesiologist's physiologic state I-III patients,
- written consent who agreed to participate in the study.
You may not qualify if:
- BMI\>35
- who do not want to be included in the study by not signing the voluntary consent form,
- Local infection, hematoma, hernia, neoplasm etc. in the area to be blocked. found,
- Coagulopathy, hepatic or renal failure,
- Allergic to a local anesthetic agent or one of the drugs used in the study,
- Having a history of chronic opioid and corticosteroid use,
- who cannot use the patient-controlled analgesia system and have a psychiatric disease,
- with operative time less than 20 minutes and more than 120 minutes for better standardization of studies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Samsun Research and Education Hospital
Samsun, 55090, Turkey (Türkiye)
Related Publications (4)
Seo SS, Kim OG, Seo JH, Kim DH, Kim YG, Park BY. Comparison of the Effect of Continuous Femoral Nerve Block and Adductor Canal Block after Primary Total Knee Arthroplasty. Clin Orthop Surg. 2017 Sep;9(3):303-309. doi: 10.4055/cios.2017.9.3.303. Epub 2017 Aug 4.
PMID: 28861197RESULTDesmet M, Balocco AL, Van Belleghem V. Fascia iliaca compartment blocks: Different techniques and review of the literature. Best Pract Res Clin Anaesthesiol. 2019 Mar;33(1):57-66. doi: 10.1016/j.bpa.2019.03.004. Epub 2019 Apr 17.
PMID: 31272654RESULTVermeylen K, Soetens F, Leunen I, Hadzic A, Van Boxtael S, Pomes J, Prats-Galino A, Van de Velde M, Neyrinck A, Sala-Blanch X. The effect of the volume of supra-inguinal injected solution on the spread of the injectate under the fascia iliaca: a preliminary study. J Anesth. 2018 Dec;32(6):908-913. doi: 10.1007/s00540-018-2558-9. Epub 2018 Sep 24.
PMID: 30250982RESULTPehora C, Pearson AM, Kaushal A, Crawford MW, Johnston B. Dexamethasone as an adjuvant to peripheral nerve block. Cochrane Database Syst Rev. 2017 Nov 9;11(11):CD011770. doi: 10.1002/14651858.CD011770.pub2.
PMID: 29121400RESULT
Study Officials
- STUDY CHAIR
Mustafa Süren, Professor
Samsun Research and Education Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Masking Details
- The patient will not know which study group he is in. The anesthetist, who will perform the regional block, will give the block to be applied in a sealed envelope by an assistant staff outside the study, and at the same time, the patient will not know which block has been made. The anesthesiologist who made the block will not participate in the pain follow-up of the patients. Postoperative pain assessment and data collection will be performed by another investigator blinded to the study.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Anesthesiologist, Principal Investigator
Study Record Dates
First Submitted
July 29, 2023
First Posted
August 7, 2023
Study Start
August 10, 2023
Primary Completion
December 31, 2023
Study Completion
January 15, 2024
Last Updated
April 11, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share
Researched data and statistical analyzes will be available from the journal in which the clinical study was published